ArticleArchives of public health = Archives belges de sante publique2026
Analysis and prediction of the trends in diabetes mellitus mortality in Chinese residents from 2008 to 2021.
Article in Archives of public health = Archives belges de sante publique, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundChina is one of the crucial countries with a significant number of diabetes patients, but only a limited number of studies on diabetes mellitus (DM) mortality rates have been reported among the Chinese population. This study examined trends in diabetes mortality in China from 2008 to 2021 and projected future rates from 2022 to 2030, providing evidence to guide prevention and control strategies.
methodsAnnual diabetes mortality data were obtained from the China Death Surveillance Dataset (2008–2021). Age-standardized mortality rate (ASMR) was calculated using the direct method, referencing the Sixth National Census population. Trends in diabetes mortality were analyzed via joinpoint regression to derive the annual percentage change (APC) and average annual percentage change (AAPC), and to assess the trends. Finally, a GM(1,1) model was constructed to predict the crude mortality rate (CMR) and ASMR of diabetes until 2030.
resultsFrom 2008 to 2021, the diabetes mortality rates in China rose from 9.72 to 18.88 per 100,000, while the ASMR rose from 10.59 to 12.37 per 100,000 (AAPC: 1.198%; 95% CI: 0.182%, 2.224%). A rising trend was observed in males (AAPC: 1.874%; 95% CI: 0.591%, 3.118%), in rural areas (AAPC: 1.992%; 95% CI: 1.108%, 2.884%), in the western region (AAPC: 3.857%; 95% CI: 2.249%, 5.491%), and in the 65-and-over age group (AAPC: 1.938%; 95% CI: 0.537%, 3.358%) from 2008 to 2021. By 2030, the CMR and ASMR for diabetes are projected to reach 31.26 and 14.44 per 100,000, respectively.
conclusionFrom 2008 to 2021, diabetes mortality rates in China showed an increasing trend, with disparities observed across sex, residence, region, and age groups. The increasing trend of diabetes mortality will continue in the future. Healthcare organizations and policymakers need to focus on male groups, rural areas, the western region and the population aged 65 and above, while implementing robust diabetes prevention strategies targeting younger cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.